There is no current diagnosis of Type I diabetes, diabetic ketoacidosis, or pancreatitis
In May 2024, Hims & Hers began selling a compounded version of the GLP-1 drug semaglutide for a price that was 85% lower than Wegovy and also considerably less expensive than Ozempic
hdl:10536/DRO/DU:30050819
The preservation of full efficacy, despite lower potency, suggests that the compound effectively engages key activation-relevant residues within the receptor binding cavity, in agreement with predicted computational analyses
Although semaglutide is effective, many people discontinue it due to high costs, persistent side effects, medication shortages, weight-loss plateaus, reaching their goal weight, or simply feeling physically or mentally tired of long-term injections
11 , R62 (2007)